Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03HDL
|
|||
| Drug Name |
MK 8719
|
|||
| Indication | Progressive supranuclear palsy [ICD-11: 8A00.10; ICD-10: G23.1] | Phase 1 | [1] | |
| Company |
Alectos Therapeutics Vancouver, Canada Merck Whitehouse Station, NJ
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Beta-N-acetylhexosaminidase (OGA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.